Symptom Management in African-American Men With Localized Prostate Cancer

This study is currently recruiting participants.

Verified by National Cancer Institute (NCI), November 2008

First Received: October 4, 2008 Last Updated: February 6, 2009 History of Changes

Sponsored by:	Baylor College of Medicine
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00767845

Purpose

RATIONALE: Gathering information about symptom management from patients with localized prostate cancer may help doctors improve patients' quality of life.

PURPOSE: This clinical trial is studying symptom management in African-American men with localized prostate cancer.

Condition	Intervention
Cancer-Related Problem/Condition Prostate Cancer	Other: questionnaire administration Other: survey administration Procedure: psychosocial assessment and care

MedlinePlus related topics: Cancer Palliative Care Prostate Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Health Services Research
Official Title:	PROSTATE CANCER SYMPTOM MANAGEMENT FOR LOW LITERACY MEN

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:

Symptom management taxonomy

Estimated Enrollment:	30
Study Start Date:	May 2008
Estimated Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)

Detailed Description:

OBJECTIVES:

Develop a symptom management intervention for African-American men treated for localized prostate cancer, with a particular emphasis on low health literacy men.

OUTLINE: Participants are interviewed by the principal investigator over the phone or meet the principal investigator at the Veterans Administration prostate cancer clinic. If the interview is conducted in the clinic, it is held in a private room in the clinic.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

Biopsy-proven localized prostate cancer
- Has received treatment for prostate cancer
Patient self-identifies as being of African-American descent

PATIENT CHARACTERISTICS:

Able to speak and read in English
Has an address in order to receive study materials by mail (a street address or post office box)
Has either a telephone in order to be interviewed OR is able to meet the principal investigator at the Veterans Administration prostate clinic and be interviewed there

PRIOR CONCURRENT THERAPY:

See Disease Characteristics

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00767845

Locations

United States, Texas
Dan L. Duncan Cancer Center at Baylor College of Medicine	Recruiting
Houston, Texas, United States, 77030
Contact: David Latini, PhD 877-794-7852 canceroutcomes@bcm.edu

Sponsors and Collaborators

Baylor College of Medicine

Investigators

Principal Investigator:

David Latini, PhD

Baylor College of Medicine

More Information

Additional Information:

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers:	CDR0000600455, BCM-H-19323
Study First Received:	October 4, 2008
Last Updated:	February 6, 2009
ClinicalTrials.gov Identifier:	NCT00767845 History of Changes
Health Authority:	Unspecified

Keywords provided by National Cancer Institute (NCI):

psychosocial effects/treatment
stage I prostate cancer
stage II prostate cancer
stage III prostate cancer

Study placed in the following topic categories:

Prostatic Diseases
Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site
Prostatic Diseases
Genital Neoplasms, Male

Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009